NRx (New Prescription)
NRx is an important measure of ongoing prescribing activity, but it should not be conflated with new patient starts. Because NRx captures prescription renewal events rather than first-time use, it reflects continuity of care as much as it does new demand. Each NRx event may also involve a clinical reassessment – i.e., the prescriber may run updated labs and adjust dosage or therapy accordingly, which can generate additional claims activity worth tracking.
TL;DR
NRx refers to a new prescription event for a medication a patient is already on, typically issued when a prior script or its refills run out.
CATEGORY
Abbreviations
WHO IT IMPACTS
Pharma brand and commercial teams, sales operations, and market analytics professionals
RELATED TERMS
DEFINITION
NRx refers to a new prescription issued for a medication a patient is already being treated with – typically when a prior prescription or its refills have been exhausted and the patient needs a fresh script to continue their therapy. A single patient can accumulate multiple NRx events for the same drug over the course of a long-term treatment plan.
WHY IT MATTERS
- Reflects continuity of care rather than new patient demand, so it should not be confused with new patient starts
- Provides an ongoing signal of prescribing activity across long term treatment, not just a one time snapshot
- Often tied to clinical reassessment, which can generate additional claims activity worth tracking alongside the prescription itself
- Helps commercial and analytics teams understand the true rhythm of therapy renewal for chronic and long term conditions
Example: A patient managing hypertension with a branded medication will generate a new NRx each time their prescription lapses and is renewed at a follow-up appointment – potentially several times a year, across many years of treatment.